Keith Holliday, STAAR Surgical Company (STAA)’s insider Sold 2,188 Shares; Payden & Rygel Upped By $14.47 Million Its Coresite Realty (COR) Position

Payden & Rygel increased Coresite Realty Corp (COR) stake by 3343.59% reported in 2017Q3 SEC filing. Payden & Rygel acquired 130,400 shares as Coresite Realty Corp (COR)’s stock rose 15.80%. The Payden & Rygel holds 134,300 shares with $15.03 million value, up from 3,900 last quarter. Coresite Realty Corp now has $5.00 billion valuation. The stock increased 0.82% or $0.84 during the last trading session, reaching $104. About 134,633 shares traded. CoreSite Realty Corporation (NYSE:COR) has risen 35.38% since March 22, 2017 and is uptrending. It has outperformed by 18.68% the S&P500.

The Chief Technology Officer of Staar Surgical Co, Keith Holliday a few days ago received approximately $35,065 USD for 2,188 shares in the Staar Surgical Co firm at an approx. $16.0 a share. He also unloaded 1,458 shares with value $23,401 USD in the last 30 days. Dated March 22, 2018, this significant sale by Keith Holliday was revealed in the a legal document that was filed together with the Washington-based Security and Exchange Commission. It is freely available for review here. The probability of this deal remaining disregarded is very low, with the Chief Technology Officer currently holding 43,781 shares —- that is 0.11% of the market cap of Staar Surgical Co.

The stock decreased 0.31% or $0.05 during the last trading session, reaching $16.3. About 70,486 shares traded. STAAR Surgical Company (NASDAQ:STAA) has risen 79.17% since March 22, 2017 and is uptrending. It has outperformed by 62.47% the S&P500.

STAAR Surgical Company, together with its subsidiaries, designs, develops, makes, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company has market cap of $675.11 million. The firm provides Visian implantable collamer lenses to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It currently has negative earnings. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery.

Since March 19, 2018, it had 0 insider buys, and 2 insider sales for $130,673 activity. $107,272 worth of STAAR Surgical Company (NASDAQ:STAA) was sold by Mason Caren L. Another trade for 1,458 shares valued at $23,401 was made by Holliday Keith on Tuesday, March 20.

Investors sentiment decreased to 1.79 in 2017 Q3. Its down 0.07, from 1.86 in 2017Q2. It worsened, as 6 investors sold STAAR Surgical Company shares while 16 reduced holdings. 14 funds opened positions while 27 raised stakes. 31.59 million shares or 1.78% more from 31.04 million shares in 2017Q2 were reported. Ameritas Ptnrs reported 3,235 shares. Tower Research Capital Limited Liability Com (Trc) reported 5,311 shares. Grandeur Peak Global Advisors Ltd Company reported 0.83% in STAAR Surgical Company (NASDAQ:STAA). Swiss Retail Bank holds 0% in STAAR Surgical Company (NASDAQ:STAA) or 49,900 shares. Citadel Advisors Llc invested in 0% or 13,836 shares. D E Shaw And Communications owns 0% invested in STAAR Surgical Company (NASDAQ:STAA) for 23,410 shares. 293,438 were accumulated by Tiverton Asset Mngmt Limited Liability Corporation. Creative Planning holds 0% in STAAR Surgical Company (NASDAQ:STAA) or 40,895 shares. Northern stated it has 0% of its portfolio in STAAR Surgical Company (NASDAQ:STAA). Putnam Invs Lc holds 0.2% of its portfolio in STAAR Surgical Company (NASDAQ:STAA) for 6.88 million shares. Jacobs Levy Equity Mgmt stated it has 10,470 shares. Broadwood has 10.86 million shares. Deutsche Commercial Bank Ag has 0% invested in STAAR Surgical Company (NASDAQ:STAA). Weiss Multi holds 0.01% of its portfolio in STAAR Surgical Company (NASDAQ:STAA) for 20,000 shares. Art Advisors Lc holds 16,082 shares or 0.01% of its portfolio.

Among 3 analysts covering STAAR Surgical (NASDAQ:STAA), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. STAAR Surgical has $21.0 highest and $7 lowest target. $18’s average target is 10.43% above currents $16.3 stock price. STAAR Surgical had 12 analyst reports since January 29, 2016 according to SRatingsIntel. Canaccord Genuity upgraded the stock to “Buy” rating in Monday, September 25 report. As per Sunday, October 8, the company rating was maintained by Canaccord Genuity. Canaccord Genuity maintained it with “Hold” rating and $11.0 target in Monday, September 4 report. The company was maintained on Wednesday, November 8 by Canaccord Genuity. The firm earned “Hold” rating on Friday, January 29 by Benchmark. The firm has “Buy” rating by Benchmark given on Monday, November 20. As per Friday, November 17, the company rating was maintained by Canaccord Genuity. As per Thursday, August 3, the company rating was maintained by Canaccord Genuity. Stephens maintained the stock with “Hold” rating in Thursday, March 1 report. Canaccord Genuity maintained it with “Hold” rating and $900 target in Monday, July 10 report.

Among 20 analysts covering CoreSite Realty (NYSE:COR), 12 have Buy rating, 0 Sell and 8 Hold. Therefore 60% are positive. CoreSite Realty had 61 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Thursday, August 11. Credit Suisse maintained the stock with “Hold” rating in Wednesday, January 17 report. Jefferies maintained CoreSite Realty Corporation (NYSE:COR) rating on Monday, October 23. Jefferies has “Buy” rating and $130.0 target. Citigroup maintained the stock with “Buy” rating in Friday, October 27 report. The firm has “Outperform” rating given on Tuesday, February 16 by RBC Capital Markets. As per Friday, December 16, the company rating was upgraded by KeyBanc Capital Markets. The company was maintained on Thursday, June 8 by RBC Capital Markets. The rating was maintained by Jefferies with “Buy” on Friday, September 15. The stock of CoreSite Realty Corporation (NYSE:COR) earned “Hold” rating by KeyBanc Capital Markets on Thursday, October 12. The rating was downgraded by KeyBanc Capital Markets to “Sector Weight” on Tuesday, May 2.